We are live on ! Find out more
WE

Wealth Effects Portfolio holdings

AUM $370M
1-Year Est. Return 97.79%
This Fund
S&P 500
This Quarter Est. Return
+11.76%
1 Year Est. Return
+97.79%
3 Year Est. Return
+201.58%
5 Year Est. Return
10 Year Est. Return
AUM
$320M
AUM Growth
+$8.77M
Cap. Flow
-$16M
Cap. Flow %
-5.01%
Top 10 Hldgs %
49.88%
Holding
233
New
15
Increased
67
Reduced
89
Closed
15

Sector Composition

Rank Sector Weight
1 Technology 27.23%
2 Miscellaneous 20.65%
3 Healthcare 20.43%
4 Financials 7.66%
5 Communication Services 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BGR icon
201
BlackRock Energy and Resources Trust
BGR
$438M
$203K 0.06%
15,000
-2,000
-12% -$27K
CHI
202
Calamos Convertible Opportunities and Income Fund
CHI
$1.01B
$200K 0.06%
19,080
+1,074
+6% +$11.7K
IBRX icon
203
ImmunityBio
IBRX
$8.56B
$184K 0.06%
93,000
-21,500
-19% -$48.7K
IRDM icon
204
Iridium Communications
IRDM
$5B
$174K 0.05%
10,000
-5,612
-36% -$99.2K
FXN icon
205
First Trust Energy AlphaDEX Fund
FXN
$403M
$173K 0.05%
10,500
DDD icon
206
3D Systems Corp
DDD
$575M
$165K 0.05%
93,492
-76,208
-45% -$185K
STXS icon
207
Stereotaxis
STXS
$139M
$159K 0.05%
69,060
-6,000
-8% -$16K
GLUE icon
208
Monte Rosa Therapeutics
GLUE
$1.18B
$158K 0.05%
10,099
ZENA
209
ZenaTech Inc
ZENA
$149M
$154K 0.05%
48,000
+25,000
+109% +$104K
HUMA icon
210
Humacyte
HUMA
$168M
$147K 0.05%
153,067
-54,950
-26% -$77.8K
ETJ
211
Eaton Vance Risk-Managed Diversified Equity Income Fund
ETJ
$566M
$134K 0.04%
15,150
-300
-2% -$2.65K
STKL
212
DELISTED
SunOpta
STKL
$93.1K 0.03%
24,500
+1,000
+4% +$4.54K
INDI icon
213
indie Semiconductor
INDI
$761M
$71.3K 0.02%
20,200
-9,750
-33% -$42.7K
CATX icon
214
Perspective Therapeutics
CATX
$357M
$68.8K 0.02%
25,000
-1,000
-4% -$2.85K
SCYX icon
215
SCYNEXIS
SCYX
$52.7M
$57.9K 0.02%
11,438
-1,000
-8% -$5.44K
AKBA icon
216
Akebia Therapeutics
AKBA
$270M
$25.8K 0.01%
16,000
XAIR icon
217
Beyond Air
XAIR
$3.47M
$23K 0.01%
1,584
-104
-6% -$3.4K
AUTL
218
Autolus Therapeutics
AUTL
$596M
$19.9K 0.01%
10,000
-6,000
-38% -$9.22K
CURI icon
219
CuriosityStream
CURI
$161M
-18,104
Closed -$96K
DKNG icon
220
DraftKings
DKNG
$11.9B
-5,700
Closed -$213K
FSK icon
221
FS KKR Capital
FSK
$3.44B
-16,100
Closed -$240K
IBDQ
222
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
-8,746
Closed -$220K
IONQ icon
223
IonQ
IONQ
$16B
-6,137
Closed -$377K
MP icon
224
MP Materials
MP
$9.71B
-5,525
Closed -$371K
OGN icon
225
Organon & Co
OGN
$3.62B
-33,821
Closed -$361K

Similar funds

Wealth Effects's Q4 2025 Portfolio in Review

As of Q4 2025, Wealth Effects held 233 positions worth $320M, up 2.8% from $311M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Wealth Effects withdrew a net $16M in Q4 2025, closing 15 positions and reducing 89 holdings. Its most notable exit was Ondas Inc, an estimated $1.41M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Miscellaneous and Healthcare.

Against the trend, Wealth Effects opened a new position in Fidelity Yield Enhanced Equity ETF worth $1.09M.

  • Wealth Effects's largest Q4 2025 buy was Fidelity Yield Enhanced Equity ETF: 37,980 shares worth $1.09M.
  • Wealth Effects added most to Kenvue in Q4 2025, an estimated $973K increase.
  • Wealth Effects's biggest Q4 2025 reduction was Avadel Pharmaceuticals, cutting an estimated $7.71M.
  • Wealth Effects fully exited Ondas Inc in Q4 2025, selling an estimated $1.41M.
  • Wealth Effects's ten largest holdings make up 50% of its $320M portfolio in Q4 2025.
  • Wealth Effects opened 15 new positions and closed 15 in Q4 2025.
  • Wealth Effects's portfolio value rose 2.8% quarter-over-quarter to $320M.

Based on Wealth Effects's 13F filing for Q4 2025, filed 26 Jan 2026.